Allurion Technologies, Inc. (ALUR): Total Assets
$15.77M
As of 2025-12-31
$13.99M
As of 2026-03-31
-32.5%
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $15.77M | -51.9% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $32.81M | n/a | 2026-03-30, Balance as of period end |
| 2024-09-30 | $50.70M | n/a | 2025-08-19, Balance as of period end |
| 2024-06-30 | $46.55M | n/a | 2025-08-19, Balance as of period end |
| 2024-03-31 | $59.99M | n/a | 2025-08-19, Balance as of period end |
| 2023-12-31 | $71.71M | +39.6% | 2025-08-28, Balance as of period end |
| 2022-12-31 | $51.37M | n/a | 2025-08-28, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | $15.77M | -51.9% |
| Biotricity Inc. (BTCY) | 2026-03-31 | $6.45M | +14.3% |
| Profound Medical Corp. (PROF) | 2025-12-31 | $77.47M | +10.3% |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | $25.15M | +64.6% |
| Nephros Inc (NEPH) | 2025-12-31 | $13.64M | +21.7% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | $13.96M | +1.9% |
| Spectral AI, Inc. (MDAI) | 2025-12-31 | $21.41M | +77.0% |
| Nexgel, Inc. (NXGL) | 2025-12-31 | $10.46M | -4.8% |
| DarioHealth Corp. (DRIO) | 2025-12-31 | $110.08M | -7.4% |
Compare ALUR, BTCY, PROF, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗